Oarsman Capital, Inc. Novartis Ag Transaction History

Oarsman Capital, Inc.

  • $706 Million
  • Q3 2025

A detailed history of Oarsman Capital, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Oarsman Capital, Inc. holds 4,779 shares of NVS stock, worth $628,677. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,779
Previous 5,074 5.81%
Holding current value
$628,677
Previous $614,000 0.33%
% of portfolio
0.09%
Previous 0.1%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 20, 2025
SELL
$113.5 - $129.73 $33,482 - $38,270
-295 Reduced 5.81%
4,779 $612,000
Q2 2025

Aug 01, 2025
SELL
$101.96 - $121.01 $29,058 - $34,487
-285 Reduced 5.32%
5,074 $614,000
Q1 2025

May 14, 2025
SELL
$97.14 - $115.57 $23,313 - $27,736
-240 Reduced 4.29%
5,359 $597,000
Q4 2024

Feb 12, 2025
SELL
$96.78 - $117.18 $22,065 - $26,717
-228 Reduced 3.91%
5,599 $544,000
Q3 2024

Nov 08, 2024
SELL
$106.13 - $120.89 $3,502 - $3,989
-33 Reduced 0.56%
5,827 $670,000
Q2 2024

Aug 12, 2024
SELL
$92.57 - $107.37 $30,270 - $35,109
-327 Reduced 5.29%
5,860 $623,000
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $12,194 - $13,884
-128 Reduced 2.03%
6,187 $598,000
Q4 2023

Feb 16, 2024
BUY
$92.27 - $101.54 $9,042 - $9,950
98 Added 1.58%
6,315 $637,000
Q3 2023

Oct 27, 2023
SELL
$94.73 - $105.13 $6,157 - $6,833
-65 Reduced 1.03%
6,217 $633,000
Q2 2023

Aug 10, 2023
SELL
$92.52 - $104.91 $18,041 - $20,457
-195 Reduced 3.01%
6,282 $633,000
Q1 2023

May 11, 2023
SELL
$80.03 - $92.81 $25,209 - $29,235
-315 Reduced 4.64%
6,477 $595,000
Q4 2022

Feb 09, 2023
SELL
$75.55 - $92.52 $27,575 - $33,769
-365 Reduced 5.1%
6,792 $616,000
Q3 2022

Nov 10, 2022
BUY
$74.61 - $87.26 $533,983 - $624,519
7,157 New
7,157 $544,000
Q2 2022

Aug 10, 2022
SELL
$80.52 - $93.75 $55,558 - $64,687
-690 Reduced 8.54%
7,392 $625,000
Q1 2022

May 11, 2022
BUY
$80.11 - $90.62 $44,060 - $49,841
550 Added 7.3%
8,082 $709,000
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $63,361 - $70,063
-795 Reduced 9.55%
7,532 $659,000
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $33,120 - $38,531
-405 Reduced 4.64%
8,327 $681,000
Q2 2021

Aug 12, 2021
SELL
$85.24 - $94.15 $879,591 - $971,533
-10,319 Reduced 54.17%
8,732 $797,000
Q1 2021

May 12, 2021
SELL
$83.5 - $98.47 $418,919 - $494,023
-5,017 Reduced 20.85%
19,051 $1.63 Million
Q4 2020

Feb 11, 2021
SELL
$78.07 - $94.43 $20,766 - $25,118
-266 Reduced 1.09%
24,068 $2.27 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $198,368 - $219,765
-2,415 Reduced 9.03%
24,334 $2.12 Million
Q2 2020

Aug 13, 2020
BUY
$80.93 - $91.1 $1.23 Million - $1.39 Million
15,234 Added 132.3%
26,749 $2.34 Million
Q1 2020

May 13, 2020
SELL
$70.67 - $99.01 $750,656 - $1.05 Million
-10,622 Reduced 47.98%
11,515 $949,000
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $796,854 - $900,960
9,447 Added 74.44%
22,137 $2.1 Million
Q3 2019

Nov 12, 2019
SELL
$85.54 - $94.26 $12,831 - $14,139
-150 Reduced 1.17%
12,690 $1.1 Million
Q2 2019

Aug 13, 2019
SELL
$75.4 - $92.8 $1,357 - $1,670
-18 Reduced 0.14%
12,840 $1.17 Million
Q1 2019

May 14, 2019
SELL
$75.32 - $86.15 $22,595 - $25,845
-300 Reduced 2.28%
12,858 $1.24 Million
Q4 2018

Feb 13, 2019
SELL
$73.66 - $82.02 $10,312 - $11,482
-140 Reduced 1.05%
13,158 $1.13 Million
Q3 2018

Nov 07, 2018
SELL
$66.94 - $77.43 $16,735 - $19,357
-250 Reduced 1.85%
13,298 $1.15 Million
Q2 2018

Aug 10, 2018
BUY
$64.91 - $73.36 $106,712 - $120,603
1,644 Added 13.81%
13,548 $1.02 Million
Q1 2018

May 14, 2018
BUY
$70.39 - $84.15 $7,672 - $9,172
109 Added 0.92%
11,904 $962,000
Q4 2017

Feb 08, 2018
SELL
$72.33 - $77.64 $11,934 - $12,810
-165 Reduced 1.38%
11,795 $990,000
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $886,714 - $924,149
11,960
11,960 $1.03 Million

Others Institutions Holding NVS

# of Institutions
1,599
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Oarsman Capital, Inc. Portfolio

Follow Oarsman Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email